1 year return (CAGR)
-64.52%
BridgeBio Oncology Therapeutics, Inc. Exchange (NASDAQ, USD)
BBOT
3.99
-0.17 (-4.09%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
319.90M
Price/Sales
-
Ent value
319.43M
Price/Book
0.99
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 4.15 |
| Daily high | 4.17 |
| Daily low | 3.90 |
| Daily Volume | 657K |
| All-time high | 13.73 |
| 1y analyst estimate | 24.90 |
| Beta | 0.36 |
| EPS (TTM) | -2274.89 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| BBOT | S&P500 | |
| Current price drop from All-time high | -70.94% | -1.38% |
| Highest price drop | -70.94% | -56.47% |
| Date of highest drop | 24 Sep 2026 | 9 Mar 2009 |
| Avg drop from high | -26.65% | -10.68% |
| Avg time to new high | 25 days | 12 days |
| Max time to new high | 214 days | 1805 days |
News
